Polymerase News and Research

RSS

Study reports reduced disease severity in Syrian hamsters during re-infection with SARS-CoV-2 Delta variant

Researchers studied the immune responses in Syrian hamsters re-infected with SARS-CoV-2 Delta and B.1 variants three months after the primary infection.

17 Mar 2022

Researchers evaluate predictors for mortality in hospitalized COVID-19 patients

Researchers identified independent factors associated with early and late deaths in hospitalized COVID-19 patients.

17 Mar 2022

Biomarkers to identify SARS-CoV-2 patients requiring invasive mechanical ventilation

Researchers evaluated biomarkers that could help identify COVID-19 patients needing invasive mechanical ventilation.

17 Mar 2022

Novel fusion inhibitor blocks SARS-CoV-2 spike-mediated cell-cell fusion

Researchers constructed a novel fusion inhibitor−based recombinant protein, referred to as 5−Helix, to block SARS-CoV-2 spike-mediated cell-cell fusion.

17 Mar 2022

Researchers develop extraction-free saliva RT-LAMP assay for workplace surveillance of SARS-CoV-2

Researchers developed a saliva-based, extraction-free reverse transcription loop-mediated isothermal amplification workflow for SARS-CoV-2 detection.

17 Mar 2022

Prevalence and duration of post-COVID condition in healthcare workers

A recent study assessed the physical, cognitive, psychological profile of post-COVID-19 condition in healthcare workers.

17 Mar 2022

Impact of COVID-19 measures on the future transmission of respiratory syncytial virus

A new study discussed the impact of COVID-19 measures on the future transmission of the respiratory syncytial virus in South Africa.

17 Mar 2022

Vaccine effectiveness against COVID-19 severity in the elderly

Researchers assessed vaccine effectiveness against SARS-CoV-2 infection in elderly patients before and after the spread of the SARS-CoV-2 Omicron variant of concern.

17 Mar 2022

Study explores profiles of COVID-19 vaccines across different countries

A new study analyzed the amplitude, time, and adverse events associated with COVID-19 vaccines across different countries.

17 Mar 2022

Wastewater monitoring reveals emergence and spread of SARS-CoV-2 Omicron in Alberta

Researchers utilize variant-specific RT-qPCR assays to monitor wastewater to monitor the prevalence of the Omicron and Delta variants.

16 Mar 2022

Highly sensitive PCR test for COVID-19 receives FDA emergency use authorization

A new highly sensitive, easy-to-use test for COVID-19 that requires a single swab and 15 minutes has received emergency use authorization (EUA) status from the U.S. Food and Drug Administration (FDA).

16 Mar 2022

Multisystem inflammatory syndrome as a late complication in COVID-19 infected children

Researchers determined the immune signature of the multisystem inflammatory syndrome in children among hospitalized children diagnosed with SARS‐CoV‐2 infection.

16 Mar 2022

Young adults protected by booster COVID-19 vaccine during Omicron dominant period

Researchers estimate the impact of COVID-19 booster doses on infection in a vaccinated population of young adults during Omicron-dominant period.

16 Mar 2022

Placenta found to demonstrate anti-oxidant activity against COVID-19 in full-term pregnancy

Researchers assessed the placental anti-oxidant response in the third trimester of pregnancy against SARS-CoV-2 infections.

16 Mar 2022

In silico identification of novel curcumin derivatives as potential inhibitors against SARS-CoV-2 enzymes

Researchers identified curcumin derivatives as potential inhibitors of SARS-CoV-2 enzymes.

16 Mar 2022

Novel targets to inhibit SARS-CoV-2 variants

A new study identified additional targets on SARS-CoV-2 proteins to prevent the emergence of new SARS-CoV-2 variants of concern.

16 Mar 2022

High prevalence of COVID-19 in myocardial infarction patients undergoing percutaneous coronary intervention

A team of scientists from Iran has recently estimated the prevalence of coronavirus disease 2019 (COVID-19) in myocardial infarction patients receiving a primary percutaneous coronary intervention. A considerably high prevalence of COVID-19 has been observed among study participants. The study is currently available on the Research Square* Preprint Server.

16 Mar 2022

New insight into SARS-CoV-2 nsp14 protein opens door to new drugs

In a recent research paper currently available on bioRxiv* preprint server, scientists from the University of Oxford in the United Kingdom and the University of Auckland in New Zealand identified several structural specificities of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that may serve as viable starting points for the development and optimization of viral inhibitors against coronavirus disease 2019 (COVID-19) and other future threats.

16 Mar 2022

Within-host mathematical model provides insight into dynamics of SARS-CoV-2 infection

Researchers used a within-host mathematical model to determine the dynamics of viral RNA and infectious virus titers in both aerosols and the URT.

15 Mar 2022

Ethyl lauroyl arginine hydrochloride (ELAH) nasal spray as potent antiviral against SARS-CoV-2

Researchers evaluate the virucidal effects of ELAH against SARS-CoV-2 and human coronavirus-229E in a nasal spray formulation.

15 Mar 2022

Polymerase News and Research

Study reports reduced disease severity in Syrian hamsters during re-infection with SARS-CoV-2 Delta variant

Researchers evaluate predictors for mortality in hospitalized COVID-19 patients

Biomarkers to identify SARS-CoV-2 patients requiring invasive mechanical ventilation

Novel fusion inhibitor blocks SARS-CoV-2 spike-mediated cell-cell fusion

Researchers develop extraction-free saliva RT-LAMP assay for workplace surveillance of SARS-CoV-2

Prevalence and duration of post-COVID condition in healthcare workers

Impact of COVID-19 measures on the future transmission of respiratory syncytial virus

Vaccine effectiveness against COVID-19 severity in the elderly

Study explores profiles of COVID-19 vaccines across different countries

Wastewater monitoring reveals emergence and spread of SARS-CoV-2 Omicron in Alberta

Highly sensitive PCR test for COVID-19 receives FDA emergency use authorization

Multisystem inflammatory syndrome as a late complication in COVID-19 infected children

Young adults protected by booster COVID-19 vaccine during Omicron dominant period

Placenta found to demonstrate anti-oxidant activity against COVID-19 in full-term pregnancy

In silico identification of novel curcumin derivatives as potential inhibitors against SARS-CoV-2 enzymes

Novel targets to inhibit SARS-CoV-2 variants

High prevalence of COVID-19 in myocardial infarction patients undergoing percutaneous coronary intervention

New insight into SARS-CoV-2 nsp14 protein opens door to new drugs

Within-host mathematical model provides insight into dynamics of SARS-CoV-2 infection

Ethyl lauroyl arginine hydrochloride (ELAH) nasal spray as potent antiviral against SARS-CoV-2

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Latest News